The retrieval results are limited, so I'll supplement with comprehensive medical knowledge on this topic.
Antibiotics for Chronic Gingivitis
Important note: Chronic gingivitis is primarily managed with mechanical plaque control (professional scaling, root planing, and improved oral hygiene). Antibiotics play only an adjunctive role and are not routinely recommended for uncomplicated gingivitis — their use is generally reserved for cases where microbial infection persists despite mechanical therapy, or in specific patient subgroups.
Why Antibiotics Are Used Adjunctively
As noted in Harrison's Principles of Internal Medicine (p. 1084), chronic gingival inflammation begins with bacterial plaque accumulation. The primary causative organisms include anaerobes such as Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, and Fusobacterium nucleatum.
Antibiotics Commonly Used
| Antibiotic | Route | Dose/Regimen | Notes |
|---|
| Metronidazole | Oral / Topical | 250–500 mg TID × 7–10 days | Drug of choice for anaerobic coverage; often combined with amoxicillin |
| Amoxicillin | Oral | 500 mg TID × 7–10 days | Broad-spectrum; often combined with metronidazole for synergistic effect |
| Amoxicillin + Metronidazole | Oral | Combination × 7–10 days | Most evidence-supported combination for periodontal/severe gingivitis |
| Doxycycline | Oral | 100 mg OD × 7–21 days | Tetracycline class; also has anti-collagenase/anti-inflammatory properties |
| Azithromycin | Oral | 500 mg OD × 3 days | Good tissue penetration; useful in penicillin-allergic patients |
| Clindamycin | Oral | 300 mg TID × 7 days | Reserved for penicillin-allergic patients; excellent anaerobic coverage |
| Ciprofloxacin | Oral | 500 mg BID × 7 days | Used in combination; targets gram-negative rods |
Topical / Local Delivery Agents
For localized disease, local antimicrobials are preferred to minimize systemic side effects:
- Chlorhexidine gluconate 0.12–0.2% rinse — most widely used; broad-spectrum antiseptic (not a systemic antibiotic but key adjunct)
- Minocycline microspheres (Arestin) — placed subgingivally into pockets
- Doxycycline hyclate gel (Atridox) — biodegradable subgingival gel
- Metronidazole gel — applied topically to gingival pockets
Sub-Antimicrobial Dose Doxycycline (SDD)
- Periostat (doxycycline 20 mg BID) is FDA-approved as a host modulation therapy
- At this dose, it inhibits matrix metalloproteinases (MMPs) and reduces collagen breakdown without exerting antimicrobial effects, thereby reducing antibiotic resistance risk
Key Clinical Considerations
- Antibiotics alone are insufficient — mechanical debridement must precede or accompany antibiotic therapy.
- Microbial culture/sensitivity testing is advisable before prescribing, especially in refractory cases.
- Antibiotic stewardship — routine antibiotic use for mild gingivitis is discouraged due to resistance concerns.
- Special populations requiring antibiotic coverage during dental procedures:
- Infective endocarditis risk (prosthetic valves, prior IE, certain congenital heart defects) → Amoxicillin 2 g single prophylactic dose (or azithromycin/clindamycin if penicillin-allergic)
- Necrotizing ulcerative gingivitis (NUG/Vincent's angina) — a more severe form that more consistently warrants systemic antibiotics: metronidazole is first-line.
Summary
For chronic gingivitis, antibiotics are adjuncts to — never replacements for — mechanical plaque removal. Metronidazole (alone or with amoxicillin) and doxycycline have the strongest evidence base. Topical agents like chlorhexidine and local delivery doxycycline/minocycline are preferred when systemic antibiotics are not warranted.